# Arda Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arda-therapeutics

- Industry: Biotechnology
- Headquarters: San Carlos, US
- Website: www.ardatx.com
- Total disclosed funding: $51M
- Latest round: Series A (Sep 16, 2024)
- Investors on record: 13

## About

Founded in 2021 and based in California, US, Arda Therapeutics, Inc. operates as a biotechnology company that offers drug development solutions. The company was founded by its CEO, Adam Freund, and CTO, Remi-Martin Laberge. In September 2024, Arda Therapeutics, Inc. raised USD 43.3 million in Series A funding led by Andreessen Horowitz, Two Sigma Investments, RV Invest GmbH, Lilly Ventures, GV, Biovision Ventures, Valhalla Ventures, and Indicator Ventures.

Arda Therapeutics develops therapies that target and eliminate specific disease-causing cells. Using single-cell data analysis, the company identifies pathogenic cells responsible for the diseases and pinpoints specific markers on these cells for targeted therapy. The firm designs cell therapies that specifically target these markers and eliminate only the pathogenic cells.

The company plans to utilize the September 2024 funding raised to advance its lead programs in cell depletion therapies and expand its discovery platform for treating various chronic diseases.

## Funding rounds

- Series A, Sep 16, 2024, $43M — Lilly Ventures, Two Sigma Investments, GV, Andreessen Horowitz, Alumni Ventures Group, Indicator Ventures, Gaingels, Mana Ventures, Biovision Ventures, Valhalla Ventures, RV Invest GmbH, LifeLink Ventures, ExitFund
- Seed, Dec 17, 2021, $7.5M — Andreessen Horowitz

## Investors

- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Seed, Series A
- Lilly Ventures (https://capitalatlas.ai/funds/lilly-ventures) — Series A
- Two Sigma Investments (https://capitalatlas.ai/funds/two-sigma-investments) — Series A
- GV (https://capitalatlas.ai/funds/gv) — Series A
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A
- Indicator Ventures (https://capitalatlas.ai/funds/indicator-ventures) — Series A
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series A
- Mana Ventures (https://capitalatlas.ai/funds/mana-ventures) — Series A
- Biovision Ventures (https://capitalatlas.ai/funds/biovision-ventures) — Series A
- Valhalla Ventures (https://capitalatlas.ai/funds/valhalla-ventures) — Series A
- RV Invest GmbH — Series A
- LifeLink Ventures — Series A
- ExitFund (https://capitalatlas.ai/funds/exitfund) — Series A